SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors discuss the potential impact of its AI robotics spinoff and VW partnership on the company's future. Community members are analyzing the stock's technical strength, debating short squeeze possibilities, and watching for a breakout. Broader EV sector trends and Rivian's progress towards profitability are also key talking points.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as investors anticipate the company's earnings report, with community members discussing potential outcomes and price movements. Bullish sentiment seems to be fueled by the expectation of strong numbers, particularly from the company's expansion into prediction markets. Some traders are also eyeing Robinhood's potential partnership with OpenDoor, while others are concerned about the impact of overall market conditions on the stock's performance post-earnings.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as community members discuss its ongoing bidding war with Pfizer for Metsera, a company with promising obesity drug candidates, and whether NVO is overpaying. Additionally, details surrounding a potential deal with the White House to lower drug prices are circulating, sparking debate about its impact. Some traders are looking to Lilly's performance as a bellwether.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending amid community excitement around its AI-driven automation platform and recent ISO certification, which validates its AI governance. Discussions revolve around its partnerships with major tech companies like Microsoft and Nvidia, with some anticipating a potential acquisition. Despite positive developments, concerns persist regarding the CEO's ongoing share sales, creating mixed sentiment.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences ($ENVB) is trending as traders discuss its potential as the next short squeeze target, drawing comparisons to past Reddit favorites like $BYND and $AMC. Community chatter highlights the stock's low float and speculation around potential patent payouts, suggesting a possible catalyst for significant upward movement. Some traders are also pointing to recent videos made by YouTubers as a possible reason for the increased attention.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Blockchain Inc

Riot Blockchain is trending as investors debate whether the recent dip is a buying opportunity, especially relative to competitors, and potential manipulation. Community members are closely watching Bitcoin's price movement and upcoming earnings, hoping for positive AI/HPC updates. Some traders express frustration with the stock's price action despite positive news and guidance.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as the community discusses its partnership with OpenAI and potential integrations with ChatGPT, driving bullish sentiment and speculation about a short squeeze. Some traders see the recent price action as a breakout opportunity, while others remain cautious, pointing to valuation concerns and competition from established players like Adobe. Overall, the focus is on whether this AI integration can significantly impact Figma's growth trajectory and market position.

Lemonade, Inc. is a holding company, which engages in the provision of insurance services. The firm's products include renters and homeowners insurance, and pet insurance. It offers insurance coverage under the homeowners multi-peril, inland marine, and general liability lines of business. The company was founded by Daniel Asher Schreiber and Shai Wininger on June 17, 2015 and is headquartered in New York, NY.

Lemonade Inc

Lemonade Inc. is trending as the community discusses its recent post-earnings move and long-term potential, with some traders noting an overreaction and potential short squeeze while others express skepticism about its profitability. Community members are actively debating whether it can break through key resistance levels soon. Meanwhile, some traders are also monitoring ENVB for a potential short squeeze similar to Beyond Meat's earlier surge.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul C. Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Despite strong revenue growth driven by AI-powered ad tools and a surge in MAUs, PINS is trending due to concerns about missed earnings and soft Q4 guidance, leading to community frustration and a significant stock drop. Investors are debating whether the company's growth potential outweighs the earnings miss, while also watching for potential catalysts such as partnerships or a possible acquisition.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind is trending as investors discuss its catalysts and potential, including recent short interest and the impact of Blackstone's investment. Community members are highlighting the company's pipeline and revenue prospects, with some expressing optimism for a significant rise in value. Discussions also involve competitor dynamics and potential analyst upgrades following recent earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tradr Launches First-to-Market Leveraged ETF on Core Scientific, Inc.

Tradr Launches First-to-Market Leveraged ETF on Core Scientific, Inc. Tradr Launches First-to-Market Leveraged ETF on Core Scientific, Inc. PR Newswire NEW YORK, Nov. 5, 2025 COZX targets 200% long...

Two Seas Capital Comments on Outcome of Special Meeting of Core Scientific Shareholders

Two Seas Capital Comments on Outcome of Special Meeting of Core Scientific Shareholders Two Seas Capital Comments on Outcome of Special Meeting of Core Scientific Shareholders PR Newswire NEW YORK...

<ul class="summary-bullets"><li>Core Scientific shareholders declined to approve the merger at a special meeting.</li><li>Core Scientific’s stock fell 2% but the ticker witnessed strong bullish sentiment on Stocktwits.</li><li>Two Seas Capital, VanEck and proxy advisory firms ISS and Glass Lewis have previously voiced concerns about the deal.&nbsp;</li></ul>Core Scientific, Inc. (CORZ) on Thursday announced the termination of its merger agreement with CoreWeave, Inc. (CRWV) after the company’s shareholders declined to approve the merger at a special meeting.&nbsp;Following the voting results,&nbsp;<a href="https://stocktwits.com/symbol/CORZ">Core Scientific stock</a> traded over 2% lower on Thursday afternoon. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<h2 class="st-heading-2">What Was In The Merger Proposal?</h2>In July, CoreWeave proposed to purchase Core Scientific through an all-stock merger, valued at $9 billion.&nbsp;Core Scientific initially turned down the proposal, citing concerns that the bid undervalued the company.&nbsp;However, the&nbsp;firm consequently agreed and wrote to its shareholders to provide support for the merger.&nbsp;<h2 class="st-heading-2">Major Shareholders’ Opinion On The Merger&nbsp;</h2>On Tuesday,&nbsp;Two Seas Capital LP, a major&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/two-seas-capital-warns-against-core-weave-acquisition-again/cLGjZ4aR3vR">stakeholder</a> in Core Scientific had urged fellow investors to reject the merger, stating that the proposed acquisition undervalues the company's assets and future prospects.The investor suggested that Core Scientific had competitive advantages including low-cost power, robust data center management expertise, and a strong development pipeline, signaling potential substantial returns for shareholders if allowed to operate independently.On similar lines, on October 23, another shareholder,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/van-eck-opposes-core-scientific-merger-with-core-weave-citing-ai-potential/cLG4mJxR3rO">VanEck</a> said it will vote against the company’s planned merger with CoreWeave, given Core Scientific’s AI potential.Proxy advisory firms ISS and Glass Lewis have also voiced concerns, citing the market’s persistent undervaluation of the deal compared to Core Scientific’s stock price, along with the lack of protections against potential losses.Core Scientific&nbsp;stock has gained over 60% in the last 12 months.&nbsp;Also See:<a href="https://stocktwits.com/news-articles/markets/equity/etsy-names-kruti-patel-goyal-as-next-ceo-stock-slides-on-lower-sales-outlook/cLGZYvuR3w8">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/fox-stock-rallies-on-1-5-b-share-repurchase-plan-q1-beat/cLGFUZ7R3xi">Fox Stock Rallies On $1.5B Share Repurchase Plan, Q1 Beat</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Core Scientific Inc. logo is seen displayed on a smartphone screen.

Core Scientific’s Merger With CoreWeave: What Happened At The Special Meeting Of Shareholders?

Core Scientific shareholders declined to approve the merger at a special meeting.

Equity

In July, CoreWeave proposed to purchase Core Scientific through an all-stock merger, valued at $9 billion.


Core Scientific to Host Investor Conference Call and Webcast Today at 11:30 AM Eastern Time

Core Scientific, Inc. (Nasdaq: CORZ) ( Core Scientific or the Company), a leader in digital infrastructure for high-density colocation services and digital asset mining, will host a conference call...

Core Scientific Announces Termination of Merger Agreement with CoreWeave

Core Scientific, Inc. (NASDAQ: CORZ) (Core Scientific or the Company), a leader in digital infrastructure for high-density colocation services and digital asset mining, previously announced that at a...

Core Scientific Announces Preliminary Results of Special Meeting of Stockholders

Core Scientific, Inc. (Nasdaq: CORZ) (Core Scientific or the Company), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced that at a...

<ul class="summary-bullets"><li>Two Seas stated that&nbsp;Core Scientific’s valuation could double if aligned with AI infrastructure peers.</li><li>The firm stressed that the proposed acquisition undervalues the company's assets and future prospects.</li><li>Shareholder vote on the deal is scheduled on October 30.</li></ul>Two Seas Capital LP, a major stakeholder in Core Scientific, Inc. (CORZ), has urged fellow investors to reject the company's proposed acquisition by CoreWeave, Inc.(CRWV).&nbsp;In&nbsp;a&nbsp;letter released on Tuesday, the investment firm noted that the AI infrastructure sector has seen a surge in investment since the deal announcement, pushing valuations of Core Scientific's peers higher.&nbsp;<h2 class="st-heading-2">Long-Term Potential&nbsp;Vs. Acquisition Offer</h2>Two Seas Capital&nbsp;noted that if Core Scientific were valued in line with these peers, shares would exceed the $16.40 per share offered in the deal in July. The firm stressed that the proposed acquisition undervalues the company's assets and future prospects.“Had it traded in-line with these peers, Core Scientific's stock would be trading more than twice as high as the value of the CoreWeave transaction.”-Sina Toussi, Founder, President and Chief Investment Officer, Two Seas Capital.The firm said Core Scientific possesses competitive advantages including low-cost power, robust data center management expertise, and a strong development pipeline, signaling potential substantial returns for shareholders if allowed to operate independently.This is not the first time&nbsp;Two Seas Capital has&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/two-seas-capital-urges-core-scientific-shareholders-to-reject-core-weave-deal/chDuc4LR3Jd">urged shareholders</a> to reject the deal. In September, the firm issued a&nbsp;similar letter to shareholders&nbsp;criticizing&nbsp;the deal as undervalued, poorly structured, and insufficiently vetted.<h2 class="st-heading-2">What Are Stocktwits Users Saying?&nbsp;</h2>Core Scientific stock traded over 4% higher on mid-morning, Tuesday. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:936/102;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_28_112624_png_8721a2391c.webp" alt="CORZ’s Sentiment Meter and Message Volume as of 11:05 a.m. ET on Oct. 28, 2025 | Source: Stocktwits" width="936" height="102"><figcaption>CORZ’s Sentiment Meter and Message Volume as of 11:05 a.m. ET on Oct. 28, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 1,100% increase in user message&nbsp;count as of Tuesday morning.&nbsp;A bullish Stocktwits user said&nbsp;the merger is unlikely to go through.<stembedurl>https://stocktwits.com/GordonGekko888/message/633966923</stembedurl>Meanwhile, another user called the&nbsp;Two Seas letter a&nbsp;“drowning level event.”<stembedurl>https://stocktwits.com/xtianus/message/633986423</stembedurl>Investors are scheduled to vote on the transaction at a special meeting on October 30.&nbsp;Earlier, on October 23, another shareholder,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/van-eck-opposes-core-scientific-merger-with-core-weave-citing-ai-potential/cLG4mJxR3rO">VanEck</a> said it will vote against the company’s planned merger with CoreWeave, given&nbsp;Core Scientific’s AI potential.Core Scientific stock has gained over 46% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palo-alto-networks-launches-cortex-agenti-x-to-automate-cybersecurity-response/cLGjS10R3Hv">Palo Alto Networks Launches Cortex AgentiX To Automate Cybersecurity Response</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Core Scientific provides digital infrastructure for bitcoin mining and high-performance computing | Source: Core Scientific

Two Seas Capital Warns Against CoreWeave Acquisition Again

Two Seas stated that Core Scientific’s valuation could double if aligned with AI infrastructure peers.

Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects

Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects PR Newswire NEW YORK, Oct. 28, 2025 Issues...

Core Scientific, Inc. (CORZ) Reports Q3 Loss, Misses Revenue Estimates

Core Scientific, Inc. (CORZ) delivered earnings and revenue surprises of +45.88% and -24.33%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Core Scientific Announces Fiscal Third Quarter 2025 Results

Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal third quarter...

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

$HOOD

$APP

$FIG

$SNAP

Which earnings release are you most excited for after the close?  
 
Drop a comment for others.

Current Price	$21.51
Prev Close	$21.74
Open	$22.12
Dividend Yield	0.00%
50-Day Moving Average	$17.41
Beta	1.55
Avg. Volume	19.22M
PE Ratio	156.07

52-Week High	$23.63
52-Week Low	$6.20
Market Capitalization	$6.74B
EPS (Annual)	-$4.39
Price to Book	-5.94
Revenue Per Employee	$1.57M
Enterprise Value/EBITDA	N/A

CORZ
Core Scientific Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CORZ News

CORZCore Scientific Inc